Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Abilify Discmelt - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Abilify Discmelt

Approved

STANDARD

Abilify Discmelt

Korea Otsuka Pharmaceutical Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 97a0a7656183f47f
Company: Korea Otsuka Pharmaceutical Co., Ltd.
Type: Standard

Approval Details

Approval Id: 97a0a7656183f47f
Drug Approval Philippines Name: Abilify Discmelt
Product Name: Abilify Discmelt
Registration Number: DR-XY45588
Brand Name: Abilify Discmelt
Generic Name: Aripiprazole
Dosage Form: Orally Disintegrating Tablet
Dosage Strength: 10mg
Manufacturer: Korea Otsuka Pharmaceutical Co., Ltd.
Importer: Otsuka (Phils.) Pharmaceutical, Inc.
Distributor: Otsuka (Phils.) Pharmaceutical, Inc.
Company Detail Path: /organization/korea-otsuka-pharmaceutical-co-ltd
Issuance Date: 27 May 2022
Expiry Date: 06 September 2026
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

97a0a7656183f47f

Type

Standard

Back to Philippines FDA Approvals